Medical Countermeasures Needle-Free Influenza Vaccines: HKUMed Advances New Live-Attenuated Platforms with Cross-Subtype PotentialGlobal Biodefense StaffMay 9, 2025
Medical Countermeasures Repositioning Smallpox Vaccines for a New Threat: MpoxGlobal Biodefense StaffMay 8, 2025
Medical Countermeasures New Monoclonal Antibodies Offer Hope for Universal Influenza TreatmentGlobal Biodefense StaffMay 1, 2025
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
ReAlta Development of RLS-0071 as Acute Radiation Syndrome Medical Countermeasure Medical Countermeasures March 28, 2024 …
Rafa Laboratories Partners with BARDA to Advance New Design for Pediatric Atropine Autoinjectors CBRNE March 20, 2024 …
Primmune Therapeutics Awarded DTRA Funding for Lassa Fever Antiviral Medical Countermeasures March 20, 2024 …
Optimizing Medical Countermeasure Development: GUIDE Program Harnesses AI Against Biological Threats Medical Countermeasures February 28, 2024 …
BARDA Award to UMSOM Aims to Advance Radiation Medical Countermeasures Medical Countermeasures February 26, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024 …
Study Shows Potential Benefits of Newer, Non-Egg-Based Flu Vaccines Medical Countermeasures January 31, 2024 …
DARPA Announces EQUIP-A-Pharma Program to Advance Agile Pharmaceutical Manufacturing Medical Countermeasures January 28, 2024 …
NIAID Funding Development of Biomarkers and Tools for Radiation Emergency Triage Medical Countermeasures January 25, 2024 …
Promising New ‘circRNA’ Vaccines Explored in CEPI-HMRI Collaboration Medical Countermeasures January 25, 2024 …
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024 …
BARDA Funds Next Stage of CRISPR-Based Bacteriophage Therapy Medical Countermeasures January 23, 2024 …
NanoViricides’ Phase 1 Broad-Spectrum Antiviral Highly Effective for Mpox and Smallpox Medical Countermeasures November 14, 2023 …
